Effects of different doses of remifentanil in patients ventilated in Pressure Support Ventilation (PSV) vs Neurally Adjusted Ventilatory Assist (NAVA) - ND

• Conditions: Acute Respiratory Failure (ARF) or with a difficult weaning in patients ventilated; MedDRA version: 9.1Level: LLTClassification code 10001053; MedDRA version: 9.1Level: LLTClassification code 10003541; MedDRA version: 9.1Level: LLTClassification code 10049683

• Registration Number: EUCTR2009-010366-28-IT
• Lead Sponsor: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-06-18
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients admitted in Intensive Care Unit with ARF or a difficult weaning agitated or poorly cooperating
informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

age<18 or >85 years; gastro-esophageal diseases or surgery in the previous 3 months; hemodynamic instability despite adequate filling (i.e. need for continous infusion of epinephrine or vasopressin or dopamine or norepinephrine).

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified